JPMORGAN CHASE & CO - CEREVEL THERAPEUTICS HLDNG I ownership

Back to all holdings Add to watchlist

CEREVEL THERAPEUTICS HLDNG I's ticker is and the CUSIP is 15678U908. A total of 4 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2023$292,468
+10.0%
9,200
-15.6%
0.00%–
Q1 2023$266,000
+831150.0%
10,900
+990.0%
0.00%–
Q4 2022$32
-100.0%
1,000
-98.3%
0.00%–
Q4 2021$1,942,000–59,900–0.00%–
 Download
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2021
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 113,300$3,601,8070.01%
JANE STREET GROUP, LLC 76,300$2,425,5770.00%
SIMPLEX TRADING, LLC 17,000$5400.00%
JPMORGAN CHASE & CO 9,200$292,4680.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders